Cargando…
Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment
The standard treatment for neovascular age-related macular degeneration (nAMD) consists of intravitreal anti-vascular endothelial growth factors (VEGF). However, for some patients, even maximal anti-VEGF treatment does not entirely suppress exudative activity. The goal of this study was to identify...
Autores principales: | Mantel, Irmela, Borgo, Angelica, Guidotti, Jacopo, Forestier, Edwige, Kirsch, Olga, Derradji, Yasmine, Waridel, Patrice, Burdet, Frédéric, Mehl, Florence, Schweizer, Claude, Roduit, Raphaël |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802772/ https://www.ncbi.nlm.nih.gov/pubmed/33447243 http://dx.doi.org/10.3389/fphar.2020.594087 |
Ejemplares similares
-
Refractory neovascular age-related macular degeneration: time-dependent changes of central retinal thickness with anti-VEGF treatment
por: Zola, Marta, et al.
Publicado: (2020) -
Fully-automated atrophy segmentation in dry age-related macular degeneration in optical coherence tomography
por: Derradji, Yasmine, et al.
Publicado: (2021) -
Automated Quantification of Pathological Fluids in Neovascular Age-Related Macular Degeneration, and Its Repeatability Using Deep Learning
por: Mantel, Irmela, et al.
Publicado: (2021) -
Fluid dynamics between injections in incomplete anti-VEGF responders within neovascular age-related macular degeneration: a prospective observational study
por: Gigon, Anthony, et al.
Publicado: (2022) -
Personalized Atrophy Risk Mapping in Age-Related Macular Degeneration
por: Gigon, Anthony, et al.
Publicado: (2021)